Aurobindo Pharma Ltd. on Saturday reported a 79.6% increase in consolidated net profit at Rs 909 crore for the March quarter. The drug firm had reported a net profit of Rs 506 crore in the January-March quarter of the FY23 fiscal.
Revenue from operations rose to Rs 7,580 crore in the period under review as compared with Rs 6,473 crore in the year-ago period, Aurobindo Pharma said in a statement.
For the financial year ended March 31, 2024, the drugmaker reported a net profit of Rs 3,173 crore as against Rs 1,927 crore in FY23.
The company's revenue from operations rose to Rs 29,002 crore in the last fiscal as against Rs 24,855 crore in FY23.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
